Nausea Was the Most Common Side Effect Reported by GLP-1 Users 46% reported nausea as a primary side effect of GLP-1 use
We report that in pre-clinical models with significant retatrutide (RETA, LY3437943)-induced weight loss, pancreatic cancer engraftment was reduced, tumor onset was delayed, and progression was attenuated resulting in a 14-fold reduction in tumor volume compared to only 4-fold reduction in single agonist semaglutide-treated mice
Your provider tailors your plan based on your health history, goals, and how you respond over time
The effect of milk thistle, green tea, and cinnamon beverages on liver enzymes of operating room anesthesia personnel Sedlak T.W., et al
Ujvari D, Jakson I, Babayeva S, et al